A bill for an act relating to health insurance coverage for infertility.
HF2258 would require most health insurance policies, health maintenance organization contracts, and public employee health plans in Iowa to cover the diagnosis and treatment of infertility, as well as standard fertility preservation services. The bill defines infertility broadly and sets out medical criteria for when a person is considered infertile, including time-based standards for failure to conceive and a provider-based diagnosis using recognized medical guidelines. It also requires coverage for up to three completed oocyte retrievals with unlimited embryo transfers, subject to ASRM guidance and medical appropriateness for single embryo transfer.
The bill further provides that fertility medications must be covered on terms no less favorable than other prescription drugs, and that deductibles, copayments, coinsurance, benefit maximums, waiting periods, and other coverage limits for infertility services cannot be less favorable than those applied to other covered benefits. It applies to policies delivered, issued, renewed, or continued in Iowa on or after July 1, 2026, and excludes certain lines of coverage such as short-term, dental, vision, Medicare supplement, long-term care, workers’ compensation, and auto medical payment coverage. The Insurance Commissioner is authorized to adopt rules to administer the section.
HF2258 would add a new insurance mandate to Iowa law by creating section 514C.37 and overriding the general uniformity-of-treatment rule for health coverage. It would require insurers, HMOs, and public employee plans to include infertility diagnosis and treatment and fertility preservation services in covered benefits, and it would regulate how those benefits are cost-shared and limited. The bill also creates a religious employer exemption and authorizes administrative rulemaking by the Insurance Commissioner, affecting insurers, employers offering health plans, and individuals seeking fertility care.
The bill was introduced and referred to the House Commerce Committee, but the provided record contains no committee transcript, vote tally, or amendment history. Based on the bill’s structure, it appears to be a policy proposal aimed at expanding reproductive and fertility-related insurance coverage, with built-in accommodations for religious employers. Because there is no recorded debate or vote in the supplied materials, the overall sentiment cannot be measured directly from legislative discussion, though the bill’s introduction suggests at least some support for considering infertility coverage expansion.
The main likely points of contention are the cost and scope of the insurance mandate, especially the requirement for up to three oocyte retrievals and unlimited embryo transfers, and whether fertility medications and related services should be treated as broadly as other covered medical benefits. Another potential issue is the religious employer exemption, which may be viewed as necessary accommodation by supporters but insufficient or overly broad by opponents depending on perspective. The bill may also draw scrutiny over how infertility is defined, which medical guidelines control coverage, and how the mandate would affect premiums and plan design for insurers and employers.